Evidence map›Paper›PMID 32695791›Full record

SynthesisFrontiers in medicine2020

Semantic and Geographical Analysis of COVID-19 Trials Reveals a Fragmented Clinical Research Landscape Likely to Impair Informativeness.

Giulia Tini, Bruno Achutti Duso, Federica Bellerba, Federica Corso, Sara Gandini, Saverio Minucci, Pier Giuseppe Pelicci, Luca Mazzarella

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. COVID term: a bilingual terminology for COVID-19.BMC medical informatics and decision making · 2021
    Article
  6. Review
  7. Repurposing anticancer drugs for the management of COVID-19.European journal of cancer (Oxford, England : 1990) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Giulia TiniDepartment of Experimental Oncology, IEO European Institute of Oncology IRCSS, Milan, Italy.
Bruno Achutti DusoDepartment of Experimental Oncology, IEO European Institute of Oncology IRCSS, Milan, Italy.
Federica BellerbaDepartment of Experimental Oncology, IEO European Institute of Oncology IRCSS, Milan, Italy.
Federica CorsoDepartment of Experimental Oncology, IEO European Institute of Oncology IRCSS, Milan, Italy.
Sara GandiniDepartment of Experimental Oncology, IEO European Institute of Oncology IRCSS, Milan, Italy.
Saverio MinucciDepartment of Experimental Oncology, IEO European Institute of Oncology IRCSS, Milan, Italy.
Pier Giuseppe PelicciDepartment of Experimental Oncology, IEO European Institute of Oncology IRCSS, Milan, Italy.
Luca MazzarellaDepartment of Experimental Oncology, IEO European Institute of Oncology IRCSS, Milan, Italy.
European Institute of Oncology · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVIDdesignendpointgeographytrial

Identifiers

PMID32695791
PMCPMC7336807
OpenAlexW3026726837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.